Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating tirzepatide in adults with Type 2 diabetes mellitus who switch from dulaglutide. The study reports results and safety data after comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dulaglutide (dulaglutide)
• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2025-08-03